OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Development of virus‐like particles‐based vaccines against coronaviruses
Chean Yeah Yong, Winnie-Pui-Pui Liew, Hui Kian Ong, et al.
Biotechnology Progress (2022) Vol. 38, Iss. 6
Open Access | Times Cited: 15
Chean Yeah Yong, Winnie-Pui-Pui Liew, Hui Kian Ong, et al.
Biotechnology Progress (2022) Vol. 38, Iss. 6
Open Access | Times Cited: 15
Showing 15 citing articles:
A perspective on SARS-CoV-2 virus-like particles vaccines
Gao Xiaoyang, Yeting Xia, Xiaofang Liu, et al.
International Immunopharmacology (2023) Vol. 115, pp. 109650-109650
Open Access | Times Cited: 17
Gao Xiaoyang, Yeting Xia, Xiaofang Liu, et al.
International Immunopharmacology (2023) Vol. 115, pp. 109650-109650
Open Access | Times Cited: 17
Interdisciplinary symposium on challenges and opportunities for vaccines: A comprehensive approach of current and future vaccine strategies to improve vaccine effectiveness in complex chronic infectious contexts
Alex S. Siebner, Marrium Habib, Vanesa Osmani, et al.
Vaccine X (2025), pp. 100615-100615
Open Access
Alex S. Siebner, Marrium Habib, Vanesa Osmani, et al.
Vaccine X (2025), pp. 100615-100615
Open Access
Chimeric Hepatitis B core virus-like particles harboring SARS-CoV2 epitope elicit a humoral immune response in mice
Sima Sazegari, Malihe Akbarzadeh Niaki, Alireza Afsharifar, et al.
Microbial Cell Factories (2023) Vol. 22, Iss. 1
Open Access | Times Cited: 12
Sima Sazegari, Malihe Akbarzadeh Niaki, Alireza Afsharifar, et al.
Microbial Cell Factories (2023) Vol. 22, Iss. 1
Open Access | Times Cited: 12
A virus-like particle candidate vaccine based on CRISPR/Cas9 gene editing technology elicits broad-spectrum protection against SARS-CoV-2
Weiqi Wang, Shen Wang, Xianyong Meng, et al.
Antiviral Research (2024) Vol. 225, pp. 105854-105854
Closed Access | Times Cited: 4
Weiqi Wang, Shen Wang, Xianyong Meng, et al.
Antiviral Research (2024) Vol. 225, pp. 105854-105854
Closed Access | Times Cited: 4
The Magic Staff: A Comprehensive Overview of Baculovirus-Based Technologies Applied to Human and Animal Health
Matías L. Pidre, Paula Nazarena Arrías, Leslie C. Amorós Morales, et al.
Viruses (2022) Vol. 15, Iss. 1, pp. 80-80
Open Access | Times Cited: 18
Matías L. Pidre, Paula Nazarena Arrías, Leslie C. Amorós Morales, et al.
Viruses (2022) Vol. 15, Iss. 1, pp. 80-80
Open Access | Times Cited: 18
Virus-mimicking nanosystems: from design to biomedical applications
Haoyang Liu, Xiao Li, Zhi‐Gang Wang, et al.
Chemical Society Reviews (2023) Vol. 52, Iss. 24, pp. 8481-8499
Closed Access | Times Cited: 7
Haoyang Liu, Xiao Li, Zhi‐Gang Wang, et al.
Chemical Society Reviews (2023) Vol. 52, Iss. 24, pp. 8481-8499
Closed Access | Times Cited: 7
Virus-like particles (VLPs)-based vaccines against COVID-19: Where do we stand amid the ongoing evolution of SARS-CoV-2?
Manish Dhawan, AbdulRahman A. Saied, Manish Sharma
Health Sciences Review (2023) Vol. 9, pp. 100127-100127
Open Access | Times Cited: 6
Manish Dhawan, AbdulRahman A. Saied, Manish Sharma
Health Sciences Review (2023) Vol. 9, pp. 100127-100127
Open Access | Times Cited: 6
Rapid and Scalable Production of Functional SARS-CoV-2 Virus-like Particles (VLPs) by a Stable HEK293 Cell Pool
Sitthiphol Puarattana-aroonkorn, Kannan Tharakaraman, Disapan Suriyawipada, et al.
Vaccines (2024) Vol. 12, Iss. 6, pp. 561-561
Open Access | Times Cited: 1
Sitthiphol Puarattana-aroonkorn, Kannan Tharakaraman, Disapan Suriyawipada, et al.
Vaccines (2024) Vol. 12, Iss. 6, pp. 561-561
Open Access | Times Cited: 1
Emerging Cationic Nanovaccines
Ana Maria Carmona‐Ribeiro, Yunys Pérez-Betancourt
Pharmaceutics (2024) Vol. 16, Iss. 11, pp. 1362-1362
Open Access | Times Cited: 1
Ana Maria Carmona‐Ribeiro, Yunys Pérez-Betancourt
Pharmaceutics (2024) Vol. 16, Iss. 11, pp. 1362-1362
Open Access | Times Cited: 1
ACE2-Decorated Virus-Like Particles Effectively Block SARS-CoV-2 Infection
Canan Bayraktar, Alişan Kayabölen, Arda Odabas, et al.
International Journal of Nanomedicine (2024) Vol. Volume 19, pp. 6931-6943
Open Access | Times Cited: 1
Canan Bayraktar, Alişan Kayabölen, Arda Odabas, et al.
International Journal of Nanomedicine (2024) Vol. Volume 19, pp. 6931-6943
Open Access | Times Cited: 1
Protein-Based Nanocarriers and Nanotherapeutics for Infection and Inflammation
Nupur Nagar, Goutami Naidu, Amit Mishra, et al.
Journal of Pharmacology and Experimental Therapeutics (2023) Vol. 388, Iss. 1, pp. 91-109
Open Access | Times Cited: 3
Nupur Nagar, Goutami Naidu, Amit Mishra, et al.
Journal of Pharmacology and Experimental Therapeutics (2023) Vol. 388, Iss. 1, pp. 91-109
Open Access | Times Cited: 3
Current Advances in Viral Nanoparticles for Biomedicine
Xianxun Sun, Tao Tian, Yindong Lian, et al.
ACS Nano (2024)
Closed Access
Xianxun Sun, Tao Tian, Yindong Lian, et al.
ACS Nano (2024)
Closed Access
ACE2-Coated Virus-Like Particles Effectively Block SARS-CoV-2 Infection
Canan Bayraktar, Alişan Kayabölen, Arda Odabas, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2023)
Open Access
Canan Bayraktar, Alişan Kayabölen, Arda Odabas, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2023)
Open Access
Baculovirus Expression of Feline Panleukopenia Virus Capsid Protein and Induces Robust Immune Responses in Cats
Erkai Feng, Manping Yan, Jingyuan Shang, et al.
Research Square (Research Square) (2023)
Open Access
Erkai Feng, Manping Yan, Jingyuan Shang, et al.
Research Square (Research Square) (2023)
Open Access
